4//SEC Filing
Santora Arthur C II 4
Accession 0001178913-22-003374
CIK 0001638097other
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 4:09 PM ET
Size
5.7 KB
Accession
0001178913-22-003374
Insider Transaction Report
Form 4
Entera Bio Ltd.ENTX
Santora Arthur C II
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2022-09-07+20,000→ 20,000 totalExercise: $2.86Exp: 2031-03-31→ Ordinary Shares, par value NIS 0.0000769 per share (20,000 underlying)
Footnotes (1)
- [F1]This grant of options was approved by the Board of Directors of Entera Bio Ltd. (the "Company") on March 31, 2021, subject to approval by the Company's shareholders, which was obtained on September 7, 2022. The options vest over a four-year period that commenced on March 31, 2021, with 25% of the options vesting on the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining three-year period.
Documents
Issuer
Entera Bio Ltd.
CIK 0001638097
Entity typeother
Related Parties
1- filerCIK 0001904746
Filing Metadata
- Form type
- 4
- Filed
- Sep 8, 8:00 PM ET
- Accepted
- Sep 9, 4:09 PM ET
- Size
- 5.7 KB